日常临床实践中的心血管风险评估:何时以及如何使用风险评分
Germana Panattoni1, Pietro Desimone2, Federica Toto1
1Division of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy.
概括
心血管疾病 (CVD) 风险评分有助于识别高风险患者,以更好地预防和管理. 本综述指导选择适合临床实践的CVD风险评分.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
- 健康风险评估健康风险评估
背景情况:
- 心血管疾病 (CVD) 是全球发病率和死亡率的主要原因之一.
- 欧洲心脏病学会指南倡导风险预测模型在管理心血管风险因素和促进健康行为.
- 风险模型对于在初级预防中识别高风险个体至关重要,以减少不良事件和过早死亡.
研究的目的:
- 对各种临床实践环境进行适当的心血管疾病 (CVD) 风险评分的选择进行审查和指导.
- 强调风险分层在初级和二级心血管疾病预防中的重要性.
- 强调在心血管疾病风险评估中整合传统和新兴的非传统标志物.
主要方法:
- 对当前欧洲心脏病学会指导方针和风险预测模型的文献综述.
- 分析心血管疾病风险评分在初级和二级预防策略中的作用.
- 关于将传统和非传统风险因素纳入风险分层的讨论.
主要成果:
- 风险模型整合了传统因素来估计10年心血管疾病风险.
- 新兴的非传统标记应与传统因素一起考虑.
- 评估残留心血管疾病风险对于最佳的二次预防和识别高风险患者进行密集管理至关重要.
结论:
- 适当选择心血管疾病风险评分对于有效的患者管理和公共卫生至关重要.
- 风险分层有助于为高风险人群量身定制预防策略和密集治疗.
- 本综述为不同临床情景选择最合适的CVD风险评分提供了指导.
相关概念视频
01:23Assessment of the Cardiovascular System I: Subjective Data
261
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
261
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
518
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
518
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
81
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
81
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
01:29Assessment of the Cardiovascular System II: Inspection
156
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Head and Neck
156
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41